Log in to search using one of your social media accounts:

 

Lexiscan (Regadenoson Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 27, 2017 Category: Drugs & Pharmacology Source Type: news

GE purchases expanded rights to Rapiscan stress agent
GE Healthcare's Life Sciences unit has purchased exclusive rights to produce...Read more on AuntMinnie.comRelated Reading: Boston Children's, GE partner on pediatric diseases FDA clears GE MBI biopsy accessory Dilon, GE ink distribution deal GE Healthcare sees strong Q3 growth in profit, revenue FDA warns of risks with Lexiscan, Adenoscan stress agents (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 3, 2017 Category: Radiology Source Type: news

Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA advierte de riesgo poco común pero grave de ataque al corazón y muerte con los medicamentos Lexiscan (regadenoson) y Adenoscan (adenosina) para la prueba nuclear de esfuerzo cardíaco
El 11 de noviembre, 2013, La Administración de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) está advirtiéndole a los profesionales de la salud del riesgo poco común pero grave de ataque al corazón y muerte, con el uso de los agentes Lexiscan (regadenoson) y Adenoscan (adenosina) para la prueba nuclear de esfuerzo cardíaco. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 1, 2016 Category: Drugs & Pharmacology Source Type: news

FDA Warns About Risk for MI, Death with Cardiac Nuclear Stress Test Agents (FREE)
By Amy Orciari Herman Cardiac nuclear stress test agents — namely, regadenoson (Lexiscan) and adenosine (Adenoscan) — pose a "rare but serious" … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 21, 2013 Category: Primary Care Source Type: news

FDA warns of risks with Lexiscan, Adenoscan stress agents
The U.S. Food and Drug Administration on November 20 issued a warning about (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 21, 2013 Category: Radiology Source Type: news

Lexiscan (regadenoson) and Adenoscan (adenosine): Drug Safety Communication - Rare but Serious Risk of Heart Attack and Death
Cases of myocardial infarction and death have occurred following the administration of Lexiscan (regadenoson) injection or Adenoscan (adenosine) infusion. (Source: FDA MedWatch)
Source: FDA MedWatch - November 20, 2013 Category: American Health Source Type: news

FDA Issues Warning on Regadenoson, AdenosineFDA Issues Warning on Regadenoson, Adenosine
Clinicians should avoid using these imaging agents for cardiac nuclear stress tests of patients with unstable angina or cardiovascular instability lest their odds of a fatal heart attack increase. News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 20, 2013 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Cardio Imaging Agent Placed on FDA Watch ListCardio Imaging Agent Placed on FDA Watch List
The agency received reports possibly linking regadenoson to fatal myocardial infarctions. The FDA will try to determine whether there is a causal relationship. News Alerts (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 15, 2013 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

Stress Test Agents Equal for Predicting CAD Risk (CME/CE)
CHICAGO (MedPage Today) -- Stress tests done with the newer vasodilator regadenoson (Lexiscan) have the same predictive power for coronary artery disease as conventional adenosine (Adenoscan), a study affirmed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 29, 2013 Category: Cardiology Source Type: news

Regadenoson with Rb-82 PET MPI helps detect obstructive CAD
The pharmacological stress agent regadenoson with rubidium-82 (Rb-82) PET myocardial (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 16, 2013 Category: Radiology Source Type: news

Stress CT Perfusion Matches SPECT for Myocardial IschemiaStress CT Perfusion Matches SPECT for Myocardial Ischemia
In stress testing using regadenoson, CT perfusion imaging resulted in a similar ability to detect or rule out myocardial ischemia, compared with the reference method, regadenoson stress testing and single-photon-emission CT imaging, in a phase 2 trial. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Stress CT perfusion matches SPECT for detecting myocardial ischemia
Stress CT perfusion imaging using regadenoson resulted in a similar ability to detect or rule out myocardial ischemia, compared with the reference method, single-photon-emission CT imaging, in a phase 2 trial. (Source: theHeart.org)
Source: theHeart.org - July 18, 2013 Category: Cardiology Source Type: news

Mallinckrodt will promote and distribute Rapiscan® in France, Italy, Belgium, and Spain
Rapidscan Pharma Solutions (RPS) EU Ltd has announced that they have come to agreement with Mallinckrodt Medical BV (Mallinckrodt) for the exclusive right to promote and distribute Rapiscan® (regadenoson) in France, Italy, Belgium and Spain. (Source: Pharmacy Europe)
Source: Pharmacy Europe - February 13, 2013 Category: Drugs & Pharmacology Source Type: news